PAX3-FKHR induces morphological change and enhances cellular proliferation and invasion in rhabdomyosarcoma

American Journal of Pathology

Volumn 159, Issue 3, 2001, Pages 1089-1096

  Anderson, John ^a   Ramsay, Alan ^a   Gould, Steve ^b,c   Pritchard Jones, Kathryn ^b,c  

^a GREAT ORMOND STREET HOSPITAL   (United Kingdom)

^b JOHN RADCLIFFE HOSPITAL   (United Kingdom)

^c INSTITUTE OF CANCER RESEARCH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

HYBRID PROTEIN; ONCOPROTEIN; PROTEIN PAX3 FKHR; TRANSCRIPTION FACTOR FKHR; TRANSCRIPTION FACTOR PAX3; UNCLASSIFIED DRUG;

ARTICLE; CANCER INVASION; CELL GROWTH; CELL INVASION; CELL PROLIFERATION; CHROMOSOME TRANSLOCATION 1; CHROMOSOME TRANSLOCATION 13; CHROMOSOME TRANSLOCATION 2; GENE CONSTRUCT; GENE EXPRESSION; HISTOGENESIS; HUMAN; HUMAN CELL; HUMAN TISSUE; MOLECULAR CLONING; PRIORITY JOURNAL; PROTEIN EXPRESSION; RHABDOMYOSARCOMA; TUMOR GROWTH; XENOGRAFT;

EID: 0034853327     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)61784-1     Document Type: Article

References (28)

1. Rhabdomyosarcoma: A new classification scheme related to prognosis
2. Classification of rhabdomyosarcomas and related sarcomas: Pathologic aspects and proposal for a new classification - An Intergroup Rhabdomyosarcoma Study
3. Agreement among and within groups of pathologists in the classification of rhabdomyosarcoma and related childhood sarcomas: Report of an international study of four pathology classifications
4. Consistent chromosomal translocation in alveolar rhabdomyosarcoma
5. Variant translocations of chromosome 13 in alveolar rhabdomyosarcoma
6. Fusion of a fork head domain gene to PAX3 in the solid tumor alveolar rhabdomyosarcoma
7. Fusion of PAX3 to a member of the forkhead family of transcription factors in human alveolar rhabdomyosarcoma
8. Fusion of PAX7 to FKHR by the variant t(1;13)(p36;q14) translocation in alveolar rhabdomyosarcoma
9. Gains, losses, and amplification of genomic material in rhabdomyosarcoma analyzed by comparative genomic hybridization
10. Frequent occurrence of p53 mutations in rhabdomyosarcoma and leiomyosarcoma, but not in fibrosarcoma and malignant neural tumors
11. The MDM2 oncoprotein is overexpressed in rhabdomyosarcoma cell lines and stabilizes wild-type p53 protein
12. Activation of an imprinted allele of the insulin-like growth factor II gene implicated in rhabdomyosarcoma
13. Disruption of imprinted genes at chromosome region 11p15.5 in pediatric rhabdomyosarcoma
14. Intergroup Rhabdomyosarcoma Study: Update for pathologists
15. Immunobiochemical and molecular biologic characterization of the cell proliferation-associated nuclear antigen that is defined by monoclonal antibody Ki-67
16. Coexpression of intermediate filament polypeptides in human fetal and adult tissues
17. Embryonic activation of the myoD gene is regulated by a highly conserved distal control element
18. High intrinsic radiosensitivity of a newly established and characterized human embryonal rhabdomyosarcoma cell line
19. Common and variant gene fusions predict distinct clinical phenotypes in rhabdomyosarcoma
20. Insulinlike growth factor II and PAX3-FKHR cooperate in the oncogenesis of rhabdomyosarcoma
21. PAX3 and PAX7 exhibit conserved cis-acting transcription repression domains and utilize a common gain of function mechanism in alveolar rhabdomyosarcoma
22. The PAX3-FKHR fusion protein created by the t(2;13) translocation in alveolar rhabdomyosarcomas is a more potent transcriptional activator than PAX3
23. Tumor-specific PAX3-FKHR transcription factor, but not PAX3, activates the platelet-derived growth factor alpha receptor
24. Transcriptional modulation of the anti-apoptotic protein BCL-XL by the paired box transcription factors PAX3 and PAX3/FKHR
25. Hormone-dependent tumor regression in vivo by an inducible transcriptional repressor directed at the PAX3-FKHR oncogene
26. Induction of apoptosis in rhabdomyosarcoma cells through down-regulation of PAX proteins
27. Pax3 functions in cell survival and in pax7 regulation
28. cDNA microarrays detect activation of a myogenic transcription program by the PAX3-FKHR fusion oncogene